CD34+ Selected ASCT for Aggressive Lymphomas

Clinical trial NCT02646098 · COMPLETED

Trial details

NCT number: NCT02646098
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Non-Hodgkin Lymphomas

Start date: 2015-11-02
Primary completion: 2018-10-11
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.